Guerbet

GBT

FR0000032526

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 11:36:58 2024-04-19 am EDT			5-day change	1st Jan Change
33.8 ^EUR	+2.27%		+0.90%	+73.33%

Apr. 09	Guerbet: CE certificate for a platform	CF
Apr. 09	Intrasense: awarded CE certificate	CF

Guerbet SA Announces Consolidated Sales Results for the First Quarter Ended March 31, 2021

April 22, 2021 at 11:45 am EDT

Guerbet SA announced consolidated sales results for the first quarter ended March 31, 2021. For the quarter, the company reported revenue of €176.3 million against €197.3 million a year ago.

Latest news about Guerbet

Guerbet: CE certificate for a platform	Apr. 09	CF
Intrasense: awarded CE certificate	Apr. 09	CF
Guerbet SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Guerbet: results exceed expectations, share price rises	Mar. 21	CF
Guerbet: two appointments to the executive committee	Mar. 11	CF
CAC40: gloomy end to the week, timid weekly gain (+0.7%)	Feb. 09	CF
Guerbet: sales growth of 4% by 2023	Feb. 09	CF
Guerbet SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
Guerbet SA(ENXTPA:GBT) dropped from S&P Global BMI Index	23-09-18	CI
Guerbet SA completed the acquisition of 17.82% stake in Intrasense SA.	23-06-04	CI
Global markets live: Boeing, Google, Meta, Sonos...	23-05-29
Guerbet Announces Management Appointments	23-05-26	CI
Applied Radiology and Guerbet Launch 'Elucirem (Gadopiclenol) Injection	23-05-23	CI
Guerbet SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Guerbet SA Provides Revenue Guidance for the Second Half and Full Year 2023	23-03-22	CI
Guerbet SA launched a takeover bid to acquire remaining 61.32% stake in Intrasense SA for ?14 million.	23-02-21	CI
Guerbet Releases First Production Batch of Elucirem (Gadopiclenol) Injection, a Novel New Macrocyclic GBCA for Use in Contrast-Enhanced Magnetic Resonance Imaging	23-02-02	CI
Guerbet to Launch Voluntary Tender Offer for Intrasense After Acquiring 39% Stake	23-01-11	MT
Intrasense SA announced that it has received €8.8 million in funding from Guerbet SA	23-01-10	CI
Guerbet SA Revises Group Earnings Guidance for the Year 2022	22-10-20	CI
Guerbet SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-27	CI
France's Guerbet Wins Public Grant To Develop Technology For Early Detection Of Pancreatic Cancer	22-09-27	MT
Guerbet's Contrast-enhanced MRI Agent Elucirem Wins US FDA Nod	22-09-22	MT
Guerbet Announces U.S. Food and Drug Administration Approval of Elucirem (Gadopiclenol)	22-09-21	CI
Guerbet SA(ENXTPA:GBT) added to S&P Global BMI Index	22-09-19	CI

Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (55.4%); - MRI products (32.7%); - other (11.9%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2023 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Europe accounts for 39.7% of net sales.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-04-24 - Q1 2024 Sales and Revenue Release

More about the company

Income Statement Evolution

More financial data

Ratings for Guerbet

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

33.8 EUR

Average target price

38.63 EUR

Spread / Average Target

+14.30%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
GUERBET	+73.33%	445M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-11.43%	13.99B
IRAY TECHNOLOGY COMPANY LIMITED	-42.51%	2.73B
SONOSCAPE MEDICAL CORP.	-21.84%	2.23B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-15.46%	1.4B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+35.01%	524M
DETECTION TECHNOLOGY OYJ	-2.19%	216M
VIEWORKS CO., LTD.	+1.11%	182M
INTROMEDIC CO., LTD.	-.--%	168M

Medical Imaging Systems

Guerbet

Equities

GBT

FR0000032526

Advanced Medical Equipment & Technology

Guerbet SA Announces Consolidated Sales Results for the First Quarter Ended March 31, 2021

Latest news about Guerbet

Chart Guerbet

Company Profile

Income Statement Evolution

Ratings for Guerbet

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Medical Imaging Systems